SAN DIEGO (AP) _ Ligand Pharmaceuticals Inc. (LGND) on Monday reported second-quarter earnings of $73.2 million.

On a per-share basis, the San Diego-based company said it had net income of $2.99. Earnings, adjusted for one-time gains and costs, came to $2.59 per share.

The drugmaker posted revenue of $90 million in the period.

Ligand expects full-year revenue of $232 million.

Ligand shares have increased 65 percent since the beginning of the year. In the final minutes of trading on Monday, shares hit $226.24, a rise of 85 percent in the last 12 months.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on LGND at